DAIC

MARCH 20, 2024

Getty Images milla1cf Wed, 03/20/2024 - 19:16 March 20, 2024 — SARS-CoV-2 , the virus that causes COVID-19 , can damage the heart even without directly infecting the heart tissue, a National Institutes of Health -supported study has found.

COVID-19 97

COVID-19 Heart Attack Heart attacks Research 97

Medical Xpress - Cardiology

MARCH 21, 2024

For Medicare beneficiaries aged 65 years and older, there is no evidence of elevated stroke risk immediately after vaccination with either brand of the COVID-19 bivalent vaccine, according to a study published in the March 19 issue of the Journal of the American Medical Association.

COVID-19 110

COVID-19 Medicare Stroke Strokes 110

HCPLive

DECEMBER 21, 2023

Data from a nationally representative survey show that, despite most US adults agree the COVID-19 and flu vaccines are safe and effective, there is discrepancy in why some may not want one or the other.

COVID-19 111

COVID-19 111

DAIC

DECEMBER 14, 2023

Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation. We could also see that unvaccinated people were at higher risk than vaccinated people.

COVID-19 96

COVID-19 Heart Rhythm Atrial Fibrillation Blood Clot 96

Open Heart

DECEMBER 14, 2023

Objective To determine the magnitude of any excess risk of mortality and hospitalisation due to COVID-19 infection in patients with congenital heart disease (CHD) in the UK healthcare system. Of patients with a positive COVID-19 test, patients with CHD were more likely than controls to be hospitalised (22.4%

COVID-19 98

COVID-19 Congenital Heart Disease Congenital Heart Disease 98

Medical Xpress - Cardiology

JANUARY 11, 2024

The emergence of COVID-19 pandemic caused as a result of severe acute respiratory syndrome-coronavirus marked a global health crisis with over 770 million cases of infection and 6 million deaths by September 6, 2023. Around 6.2% of the recovered individuals, however, face lingering symptoms such as fatigue or respiratory problems.

COVID-19 104

COVID-19 104

HCPLive

MARCH 8, 2024

After propensity score matching, patients with COVID-19 were at an increased risk for AIRD when compared with both uninfected controls and influenza-infected patients.

COVID-19 84

COVID-19 84

Medical Xpress - Cardiology

FEBRUARY 23, 2024

The results also revealed that 2MBC is accumulated in individuals with COVID-19, potentially explaining why these patients are at increased risk of thrombosis.

Blood Clot 126

Blood Clot COVID-19 Research Thrombosis 126

HCPLive

DECEMBER 30, 2023

Infants and toddlers during the COVID-19 pandemic are associated with a higher odd of positive ASQ:SE-2 screenings. The findings suggest the pandemic caused delays in children’s socio-emotional development.

COVID-19 105

COVID-19 105

HCPLive

APRIL 26, 2024

Both vaccine type and period mediated the risk of uveitis after COVID-19 vaccination in patients with a history of the ocular inflammatory event.

COVID-19 75

COVID-19 75

Frontiers in Cardiovascular Medicine

MAY 26, 2024

SARS-CoV-2 can directly invade the cardiovascular system through ACE2; Similarly, cardiovascular diseases such as hypertension and coronary heart disease can affect ACE2 levels and exacerbate the disease, and ACE2 dysregulation may also be a potential mechanism for long-term acute sequelae of COVID-19.

COVID-19 106

COVID-19 Research Cardiovascular Disease Physiology 106

Medical Xpress - Cardiology

DECEMBER 14, 2023

A large international research collaboration, led by an academic from Royal Holloway, University of London, found that blood groups could help predict the risk of venous strokes associated with the Oxford-AstraZeneca COVID-19 vaccine.

COVID-19 122

COVID-19 Academic Stroke Strokes 122

Cardiovascular Diabetology

FEBRUARY 19, 2024

Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i.

COVID-19 111

COVID-19 Thrombosis Diabetes 111

DAIC

JANUARY 11, 2024

The cumulative incidence of MACE and all- cause of mortality in COVID-19 and non-COVID-19 pneumonia groups. The results indicate a lower risk of cardiovascular disease in COVID-19 patients. The results indicate a lower risk of cardiovascular disease in COVID-19 patients.

COVID-19 74

COVID-19 Hospital Thrombosis Inpatient 74

Science Daily - Heart Disease

MARCH 20, 2024

SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the heart tissue, a new study has found. The research specifically looked at damage to the hearts of people with SARS-CoV2-associated acute respiratory distress syndrome (ARDS), a serious lung condition that can be fatal.

COVID-19 91

COVID-19 Research 91

HCPLive

FEBRUARY 19, 2024

A new study found non-hospitalized COVID-19 survivors from a Vietnam general population had a 76.1% prevalence of insomnia, with 22.8% of respondents with insomnia scoring for severe insomnia.

COVID-19 72

COVID-19 Hospital 72

Medical Xpress - Cardiology

MARCH 20, 2024

SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the heart tissue, a study has found.

COVID-19 112

COVID-19 Research Circulation 112

HCPLive

JANUARY 24, 2024

This research sheds light on increasing concerns related to maternal COVID-19 infection and its impact on neonates.

COVID-19 111

COVID-19 Research 111

HCPLive

MAY 24, 2024

Age, chronic comorbidities, and COVID-19 vaccination status in patients with IMIDs serve as risk factors for severe COVID-19 outcomes.

COVID-19 52

COVID-19 Outcomes Risk Factors 52

Open Heart

JUNE 8, 2024

Background and aim Increased mortality during the COVID-19 pandemic is not explained exclusively by COVID-19 infection and its complications. We analysed non-COVID-19 causes of mortality in a population analysis based on data from the Spanish National Institute of Statistics. compared with 2019.

COVID-19 52

COVID-19 Cancer Heart Disease 52

Frontiers in Cardiovascular Medicine

JANUARY 8, 2024

Background Coronavirus disease (COVID-19)-associated acute pericarditis has recently received much attention owing to its high frequency associated with pericardial tamponade (PT), showing unfavorable prognosis. Conclusions We encountered a unique case of COVID-19-associated acute pericarditis exhibiting hemorrhagic PT.

COVID-19 72

COVID-19 Pericarditis Hemorrhage Hospital 72

Becker's Hospital Review - Cardiology

APRIL 15, 2024

COVID-19 vaccination is not linked with sudden cardiac death among previously healthy young people, an April 11 CDC report found.

COVID-19 72

COVID-19 Sudden Cardiac Death 72

Medical Xpress - Cardiology

DECEMBER 13, 2023

Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation. This is shown in a new study published in European Heart Journal Open by researchers from Umeå University, Sweden, in one of the largest studies of its kind in the world.

COVID-19 102

COVID-19 Heart Rhythm Atrial Fibrillation Research 102

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Background & aims Coronavirus disease 2019 (COVID-19) is strongly associated with myocarditis or pericarditis risk in observational studies, however, there are still studies that do not support the above conclusion. Severe COVID-19 was not associated with myocarditis [odds ratio (OR), 1.00; 95% confidence interval (CI), 0.89–1.12;

COVID-19 69

COVID-19 Pericarditis Hospital 69

Medical Xpress - Cardiology

JANUARY 10, 2024

Patients with post-COVID-19 vaccination postural orthostatic tachycardia syndrome (POTS) all have preexisting conditions, according to a study published in the January issue of Heart Rhythm.

COVID-19 85

COVID-19 Tachycardia POTS Heart Rhythm 85

HCPLive

MAY 8, 2024

An IMID diagnosis or use of immunomodulatory medications were not shown to be a significant risk factor of severe COVID-19 outcomes.

COVID-19 59

COVID-19 Outcomes Risk Factors 59

Journal of Clinical Investigation - Cardiology

MARCH 15, 2024

In the relentless battle against the COVID-19 pandemic, the deployment of mRNA vaccines has stood out as a beacon of hope. introduces an approach to potentially enhancing the immune responses generated by COVID-19 mRNA vaccines. The study published in this issue of JCI by Fazli et al.

COVID-19 100

COVID-19 Outcomes 100

American College of Cardiology

JUNE 6, 2024

Medical education was compromised by the COVID-19 pandemic, and most cardiovascular fellowship program directors feel that cardiology fellows’ clinical training, didactic learning, academic productivity and well-being were negatively impacted, according to results from the 4th Annual Cardiovascular Program Director Survey published May 25 in JACC: (..)

COVID-19 49

COVID-19 Academic Education Article 49

Frontiers in Cardiovascular Medicine

FEBRUARY 1, 2024

In addition, with the prevalence of COVID-19 infection, more and more studies report that COVID-19 infection may lead to arteriovenous thrombosis, which could cause lower limb ischemia. After 2 months of consultation, he was ultimately diagnosed with PAES.

COVID-19 64

COVID-19 Ischemia Thrombosis 64

HeartRhythm

APRIL 30, 2024

COVID-19 has been linked to diverse electrocardiographic alterations, encompassing QTc prolongation, atrial fibrillation, ventricular tachycardia, and bradyarrhythmia1–3. Nevertheless, limited empirical evidence exists concerning infraHisian heart block associated with COVID-19.

COVID-19 40

COVID-19 Atrial Fibrillation Tachycardia 40

Frontiers in Cardiovascular Medicine

MARCH 4, 2024

The aim of the present study was to comprehensively assess symptoms and possible long-term impairments 6 and 18 months after hospitalization for severe COVID-19 infection. Methods This prospective registry included patients with PCR-confirmed COVID-19 infection requiring hospitalization.

COVID-19 64

COVID-19 Hospital Laboratory Electrocardiogram 64

The British Journal of Cardiology

JUNE 11, 2024

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included.

COVID-19 52

COVID-19 Cardiovascular Disease Angina Chest Pain 52

Frontiers in Cardiovascular Medicine

FEBRUARY 21, 2024

Introduction The prognostic ability of myocardial injury across different waves of the COVID-19 pandemic is not well established. The purpose of this study was to evaluate the prevalence and prognostic implications of myocardial injury in the first and sixth wave of COVID-19.

COVID-19 59

COVID-19 59

HCPLive

MARCH 1, 2024

In a post hoc analysis of the ACCT-2 study, a risk profile using simple hematologic parameters identified patients hospitalized with COVID-19 who benefited most from baricitinib treatment.

COVID-19 52

COVID-19 Hospital 52

Coronary Artery Disease Journal

OCTOBER 31, 2023

Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Patients with COVID-19 versus those without had significantly greater in-hospital mortality (45.2% reduction in admissions in 2020. vs. 10.7%; P < 0.001).

COVID-19 52

COVID-19 STEMI Inpatient Hospital 52

HCPLive

JANUARY 9, 2024

These data indicate the necessity of further research to clarify any associations between COVID-19 infection, the virus’s associated vaccines, and progression of vitiligo.

COVID-19 64

COVID-19 Risk Factors Research 64

HCPLive

FEBRUARY 13, 2024

Telehealth appointments, patients who prefer speaking non-English, older adults, and patients on Medicaid had lower odds of having a depression screening during the early COVID-19 pandemic.

COVID-19 52

COVID-19 Medicaid 52